Last reviewed · How we verify

Femstat 3 — Competitive Intelligence Brief

Femstat 3 (BUTOCONAZOLE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Azole Antifungal. Area: Infectious Disease.

marketed Azole Antifungal Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Femstat 3 (BUTOCONAZOLE) — Bayer.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Femstat 3 TARGET BUTOCONAZOLE Bayer marketed Azole Antifungal 1995-01-01
Vivjoa OTESECONAZOLE Mycovia Pharms marketed Azole Antifungal [EPC] Cytochrome P450 3A4 2022-01-01
Cresemba ISAVUCONAZONIUM Astellas Pharma marketed Azole Antifungal ATP-binding cassette sub-family G member 2 2015-01-01
Jublia EFINACONAZOLE Bausch Health marketed Azole Antifungal [EPC] 2014-01-01
Luzu LULICONAZOLE Bausch Health marketed Azole Antifungal [EPC] 2013-01-01
POSACONAZOLE POSACONAZOLE marketed Azole Antifungal [EPC] 2005-01-01
VORICONAZOLE VORICONAZOLE marketed Azole Antifungal [EPC] 2002-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Azole Antifungal class)

  1. · 1 drug in this class
  2. Astellas Pharma · 1 drug in this class
  3. Bayer · 1 drug in this class
  4. Journey · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Femstat 3 — Competitive Intelligence Brief. https://druglandscape.com/ci/butoconazole. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: